Ajay Prakash, Michael Offin, Manish R. Sharma, Alexander I. Spira, Sylvia Lee, Maria Quintos Baggstrom, Agathe Lepissier, Vanessa Seif, Zhaowei Hua, Kabir Mody, Jia Luo, Jiaxin Niu. "A phase 1/2, open-label study of oral S241656 (BDTX-4933) as monotherapy and in combination with other anti-cancer therapies in patients with KRAS, BRAF and other selected RAS/MAPK mutation positive malignancies.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.2_suppl.tps857